BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35012481)

  • 1. Systemic sclerosis complicated with renal thrombotic microangiopathy: a case report and literature review.
    Kong W; Wang Y; Wang H; Zhou Q; Chen J; Han F
    BMC Nephrol; 2022 Jan; 23(1):22. PubMed ID: 35012481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleroderma-associated thrombotic microangiopathy in overlap syndrome of systemic sclerosis and systemic lupus erythematosus: A case report and literature review.
    Xie X; Wang G; Cheng H; Sun L; Dong H
    Medicine (Baltimore); 2020 Oct; 99(41):e22582. PubMed ID: 33031308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleroderma Renal Crisis Complicated with Thrombotic Microangiopathy Triggered by Influenza B Virus Infection.
    Shimizu T; Iwamoto N; Okamoto M; Endo Y; Tsuji S; Takatani A; Igawa T; Umeda M; Fukui S; Sumiyoshi R; Kitamura M; Koga T; Kawashiri SY; Ichinose K; Tamai M; Nakamura H; Origuchi T; Nishino T; Kawakami A
    Intern Med; 2019 Feb; 58(3):441-445. PubMed ID: 30146597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological features and outcomes of SLE patients with renal injury characterised by thrombotic microangiopathy.
    Chen W; Liang S; Zuo K; Yang L; Zeng C; Hu W
    Clin Rheumatol; 2021 Jul; 40(7):2735-2743. PubMed ID: 33543375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studying the Role of C5-Inhibition Therapy in Scleroderma Renal Crisis-Induced Thrombotic Microangiopathy - A Review of Literature.
    Farrukh L; Steen VD; Shapiro L; Mehta S
    Semin Arthritis Rheum; 2023 Dec; 63():152256. PubMed ID: 37689027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic Microangiopathy Secondary to Systemic Sclerosis with Severe Complement Activation Not Responsive to Eculizumab: A Case Report.
    Nakamura M; Abe T; Ochiai H
    Am J Case Rep; 2022 Jun; 23():e936116. PubMed ID: 35671252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleroderma renal crisis precipitated by steroid treatment in systemic lupus erythematosus and scleroderma overlap syndrome.
    Alayoud A; Qamouss O; Hamzi A; Benyahia M; Oualim Z
    Arab J Nephrol Transplant; 2012 Sep; 5(3):153-7. PubMed ID: 22967254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory secondary thrombotic microangiopathy with kidney injury associated with systemic lupus erythematosus in a pediatric patient.
    Kaneda T; Tanaka E; Akutsu Y; Kanamori T; Mouri M; Morio T; Mori M
    CEN Case Rep; 2020 Nov; 9(4):301-307. PubMed ID: 32304042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [13-year history of scleroderma complicated by renal crisis and thrombotic microangiopathy treated with plasma exchange: A case report].
    Minami T; Akazawa M; Kanda E; Nonomura Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(2):116-20. PubMed ID: 26016639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classifications of scleroderma renal crisis and reconsideration of its pathophysiology.
    Yamashita H; Kamei R; Kaneko H
    Rheumatology (Oxford); 2019 Dec; 58(12):2099-2106. PubMed ID: 31566243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo normotensive scleroderma renal crisis six years after living-donor renal transplantation in a patient with overlapping systemic sclerosis/systemic lupus erythematosus syndrome: a case report.
    Sanada H; Hara S; Horita M; Kawahara H; Yoshida M; Takahashi Y; Tsuge S; Zoshima T; Nishioka R; Ito K; Mizushima I; Matsushita T; Kawano M
    BMC Nephrol; 2023 Dec; 24(1):355. PubMed ID: 38049714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and review of literature.
    Kello N; Khoury LE; Marder G; Furie R; Zapantis E; Horowitz DL
    Semin Arthritis Rheum; 2019 Aug; 49(1):74-83. PubMed ID: 30598332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic microangiopathy in a patient with systemic lupus erythematosus and anti-factor H autoantibodies.
    Figueiredo CR; Escoli R; Santos P; Sofia F; Lopes K
    CEN Case Rep; 2022 Feb; 11(1):26-30. PubMed ID: 34269998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of idiopathic steroid-resistant nephrotic syndrome complicated with thrombotic microangiopathy.
    Nishi K; Sato M; Ogura M; Okutsu M; Ishikura K; Kamei K
    BMC Nephrol; 2020 Aug; 21(1):323. PubMed ID: 32746791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleroderma Renal Crisis Associated With Microangiopathic Hemolytic Anemia in a Patient With Seronegative Scleroderma and Monoclonal Gammopathy.
    Riley M; Der Mesropian P; Maheshwari A; Arslan ME; Visrodia P; Salman L; Peredo-Wende R; Foulke L; Hongalgi K
    J Investig Med High Impact Case Rep; 2022; 10():23247096221074591. PubMed ID: 35152792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.
    Mejia-Vilet JM; Gómez-Ruiz IA; Cruz C; Méndez-Pérez RA; Comunidad-Bonilla RA; Uribe-Uribe NO; Nuñez-Alvarez CA; Morales-Buenrostro LE
    Clin Rheumatol; 2021 Jun; 40(6):2233-2242. PubMed ID: 33170371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Rare Case of Lupus Nephritis Presenting as Thrombotic Microangiopathy with Diffuse Pseudotubulization Possibly Caused by Atypical Hemolytic Uremic Syndrome.
    Ono M; Ohashi N; Namikawa A; Katahashi N; Ishigaki S; Tsuji N; Isobe S; Iwakura T; Sakao Y; Tsuji T; Kato A; Fujigaki Y; Shimizu A; Yasuda H
    Intern Med; 2018 Jun; 57(11):1617-1623. PubMed ID: 29434134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-onset scleroderma renal crisis induced by tacrolimus and prednisolone: a case report.
    Nunokawa T; Akazawa M; Yokogawa N; Shimada K; Hiramatsu K; Nishio Y; Sugii S
    Am J Ther; 2014; 21(5):e130-3. PubMed ID: 22836123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Complement in Autoimmune Disease-Associated Thrombotic Microangiopathy and the Potential for Therapeutics.
    Java A; Kim AHJ
    J Rheumatol; 2023 Jun; 50(6):730-740. PubMed ID: 36642429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.
    de Holanda MI; Pôrto LC; Wagner T; Christiani LF; Palma LMP
    Clin Rheumatol; 2017 Dec; 36(12):2859-2867. PubMed ID: 28905254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.